文献速递痛风与晶体性关节病

血清尿酸、痛风与合并症的关联:基于英国生物样本库的病例对照研究

Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank.
PubMed 文献 · Rheumatology (Oxford) · 2021-01-01

该病例对照研究利用英国生物样本库数据,分别分析合并症与血清尿酸(SU)的关联,以及痛风与合并症的关联。结果显示高血压、缺血性心脏病、充血性心力衰竭、高脂血症和慢性肾脏病与SU升高相关;痛风与高血压、缺血性心脏病、充血性心力衰竭、高脂血症和糖尿病的关联独立于SU。

要点

  • 高血压、缺血性心脏病、充血性心力衰竭、高脂血症和慢性肾脏病与SU升高相关。
  • 痛风与高血压、缺血性心脏病、充血性心力衰竭、高脂血症和糖尿病独立相关,且独立于SU。
  • 痛风与心血管代谢合并症的关联可能涉及非尿酸机制,如晶体沉积驱动的炎症。

核心结论

  • 合并症与SU升高相关,且痛风与心血管代谢合并症的关联独立于SU。

研究设计与样本

  • 利用英国生物样本库数据进行的病例对照研究,纳入458 781名参与者分析合并症与SU的关联,纳入10 265例痛风病例和458 781名对照分析痛风与合并症的关联。

主要发现

  • 高血压、缺血性心脏病、充血性心力衰竭、高脂血症和慢性肾脏病与SU每升高1 mg/dl的调整OR为1.10-3.14。
  • 调整包括SU在内的协变量后,痛风与高血压、缺血性心脏病、充血性心力衰竭、高脂血症和糖尿病的aOR为1.21-4.15。

临床怎么用

  • 在评估痛风患者合并症风险时,应考虑独立于SU的机制,而不仅关注降尿酸治疗。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: To examine the association between comorbidities and serum urate (SU), gout and comorbidities, and to determine whether the association between gout and comorbidities is independent of SU. METHODS: We performed a case-control study using UK Biobank data. Two separate analyses were conducted: one excluding participants with gout to investigate the association between comorbidities and SU and the other with participants with gout as the index condition to examine the association between gout and comorbidities. SU was measured at the baseline visit. Self-reported physician-diagnosed illnesses were used to define gout and comorbidities, except for chronic kidney disease (CKD), which was defined using an estimated glomerular filtration rate cut-off. Participants prescribed urate-lowering treatment were also classified as gout. Logistic regression was used to examine associations. Odds ratios (ORs) and 95% CIs were calculated and adjusted for covariates including comorbidities and SU. RESULTS: Data for 458 781 UK Biobank participants were used to examine the association between comorbidities and SU. There was an association between hypertension, ischaemic heart disease (IHD), congestive cardiac failure (CCF), hyperlipidaemia, CKD and SU with and adjusted OR (aOR) of 1.10-3.14 for each 1 mg/dl SU increase. A total of 10 265 gout cases and 458 781 controls were included in the analysis of association between gout and comorbidities. Gout associated independently with hypertension, IHD, CCF, hyperlipidaemia and diabetes, with aORs of 1.21-4.15 after adjusting for covariates including SU. CONCLUSION: Comorbidities associate with increasing SU. The association between gout and cardiometabolic comorbidities was independent of SU, suggesting separate SU-independent mechanisms such as inflammation driven by crystal deposition, pro-inflammatory genotype or non-purine dietary factors.

来源:Rheumatology (Oxford),查看原文。版权归原作者所有。

引用

  1. Sandoval-Plata G, Nakafero G, Chakravorty M, et al. Association between serum urate, gout and comorbidities: a case-control study using data from the UK Biobank. Rheumatology (Oxford). 2021. PMID: 33313843. doi:10.1093/rheumatology/keaa773

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。